SKI Market

Indian Indices

Nifty

22,529.05 27.05
(0.12%)

Sensex

73,953.31 -52.63
( -0.07%)

Bank Nifty

48,048.20 -151.30
( -0.31%)

Nifty IT

33,379.75 -59.00
( -0.18%)

Global Indices

Nasdaq

16,794.88 108.91
(0.65%)

Dow Jones

39,806.77 -196.82
(-0.49%)

Hang Seng

19,220.62 -415.60
(-2.12%)

Nikkei 225

38,946.93 -122.75
(-0.31%)

Forex

USD-INR

83.30 -0.18
(-0.21%)

EUR-INR

90.53 -0.23
(-0.25%)

GBP-INR

105.79 -0.01
(-0.01%)

JPY-INR

0.54 0.00
(-0.78%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Novartis India Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

500672

INE234A01025

301.6611406

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NOVARTIND

32.43

2762.53

EPS(TTM)

Face Value()

Div & Yield %

34.5

2.23

Back

beekay niryat ltd

Beekay Niryat consolidated net profit declines 43.41% in the September 2023 quarter

Nov 10,2023

Net profit of Beekay Niryat declined 43.41% to Rs 0.73 crore in the quarter ended September 2023 as against Rs 1.29 crore during the previous quarter ended September 2022. Sales rose 121.05% to Rs 6.30 crore in the quarter ended September 2023 as against Rs 2.85 crore during the previous quarter ended September 2022.

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	6.30	2.85	121
OPM %	0.16	4.21	-
PBDT	0.79	1.36	-42
PBT	0.75	1.36	-45
NP	0.73	1.29	-43

22,529.05 27.05 (0.12%)

73,953.31 -52.63 ( -0.07%)

48,048.20 -151.30 ( -0.31%)

33,379.75 -59.00 ( -0.18%)

16,794.88 108.91 (0.65%)

39,806.77 -196.82 (-0.49%)

19,220.62 -415.60 (-2.12%)

38,946.93 -122.75 (-0.31%)

83.30 -0.18 (-0.21%)

90.53 -0.23 (-0.25%)

105.79 -0.01 (-0.01%)

0.54 0.00 (-0.78%)